WHO’s Vaccine Experts Inadvertently Communicate to the World – Vaccines Not Proven Effective and Can Be FATAL

WHO’s Vaccine Experts Inadvertently Communicate to the World – Vaccines Not Proven Effective and Can Be FATAL By Dr. Gary G. Kohls for Global Research

Despite Its Recent Warnings About “Vaccine Hesitancy”, WHO “Experts” Acknowledge that the Claims About the Safety and Effectiveness of Vaccines were never Proven to be True

In this expose, the WHO vaccine experts admit that:

  • Vaccines can be fatal.
  • The design of safety studies makes it difficult to spot problems.
  • Safety monitoring is inadequate.
  • Vaccine adjuvants increase risk.

“The FDA receives 45% of its annual budget from the pharmaceutical industry.

The World Health Organization (WHO) gets roughly half its budget from private sources, including Pharma and its allied foundations.

And the CDC, frankly, is a vaccine company; it owns 56 vaccine patents and buys and distributes $4.6 billion in vaccines annually through the Vaccines for Children program, which is over 40% of its total budget.” — Robert F. Kennedy, Jr 

1) An admission that adjuvants can multiply the toxicity of vaccines:

“Adjuvants multiply the immunogenicity of the antigens that they are added to, and that is their intention.  It seems to me they multiply the reactogenicity in many instances, and therefore it seems to me that it is not unexpected if they multiply the incidence of adverse reactions that are associated with the antigen, but may not have been detected through lack of statistical power in the original studies.”Stephen Evans, BA, MSc, Professor of Pharmacoepidemiology at the London School of Hygiene and Tropical Medicine (LSHTM) 

2) Warnings about long-term systemic toxicity from vaccine adjuvants:

“You are correct. As we add adjuvants, especially some of the more recent adjuvants, such as the ASO1, saponin-derived adjuvants, we do see increased local reactogenicity. The primary concern, though, usually is systemic adverse events rather than local adverse events. And we tend to get in the Phase II and the Phase III studies quite good data on the local reactogenicity. Those of us in this room that are beyond the age of 50 who have had the pleasure of having the recent shingles vaccine, will know that this does have quite significant local reactogenicity. If you got the vaccine, you know that you got the vaccine. But this is not the major health concern. The major health concern which we are seeing are accusations of long term, long term effects. So, to come back to this, I’m going to once again point to the regulators. It comes down to ensuring that we conduct Phase II and the Phase III studies with adequate size and with the appropriate measurement.”Martin Howell Friede, PhD (Biochemistry) – WHO coordinator for the Initiative for Vaccine Research

3) An admission that the WHO and Big Pharma are panicking because some doctors and cover-up of vaccine injuries:

“There’s a lot of safety science that’s needed, and without the good science, we can’t have good communication. Although I’m talking about all these other contextual issues and communication issues it absolutely needs the science as the backbone. You can’t repurpose the same old science to make it sound better if you don’t have the science that’s relevant to the new problem. So, we need much more investment in safety science…The other thing that’s a trend and an issue is not just confidence in patients but confidence of health care providers. We have a very wobbly health professional front line that is starting to question vaccines and the safety of vaccines. When the front-line professionals are starting to question (the safety of vaccines) or they don’t feel like they have enough confidence about the safety to stand up to it to the person asking them the questions.  I mean, most medical school curriculums, even nursing curriculums, I mean in medical school you’re lucky if you have a half-day on vaccines. Never mind keeping up to date with all this.”Heidi Larson, PhD (in Anthropology – and therefore likely to be vaccinology-illiterate!) and Director of the Big Pharma-funded Vaccine Confidence Project

4) An admission that vaccine clinical safety trials are flawed and that vaccines damage children far more than they damage adults:

“One of the additional issues that complicates safety evaluation is that if you look at, and you struggle with the length of follow-up that should be adequate in a, let’s say a pre-licensure or even post-marketing study if that’s even possible. And again, as you mentioned pre-licensure clinical trials may not be powered enough. It’s also the subject population that you administer the adjuvant to because we’ve seen data presented to us where an adjuvant, a particular adjuvant added to a vaccine antigen did really nothing when administered to a certain population and usually the elderly, you know, compared to administering the same formulation to younger age strata.  So, these are things which need to be considered as well and further complicate safety and effectiveness evaluation of adjuvants combined with vaccine antigens.”  Marion Gruber, PhD – Director, FDA Office of Vaccines Research and Review (OVRR) and the FDA Center for Biologics Evaluation and Research (CBER)

5) A warning about the lack of vaccine safety monitoring systems:

“I think we cannot over-emphasize the fact that we really don’t have very good safety monitoring systems in many countries, and this adds to the miscommunication and the misapprehensions because we’re not able to give clear-cut answers when people ask questions about the deaths that have occurred due to a particular vaccine, and this always gets blown up in the media. One should be able to give a very factual account of what exactly has happened and what the causes of the deaths are, but in most cases there is some obfuscation at that level and therefore, there’s less and less trust then in the system.” Soumya Swaminathan, MD, WHO Chief Scientist and non-practicing Pediatrician (involved in academics and research ever since her medical training)

6) An admission that viral fragments don’t work and that adjuvants are responsible for the toxic inflammatory responses to vaccines.

Continue Reading / Global Research >>>

Sharing is caring!

Global Research

The Global Research website at www.globalresearch.ca publishes news articles, commentary, background research and analysis on a broad range of issues, focusing on social, economic, strategic and environmental issues. The Global Research website was established on the 9th of September 2001, two days before the tragic events of September 11. Barely a few days later, Global Research had become a major news source on the New World Order and Washington’s “war on terrorism”.